Understanding How Processed Fat Tissue Supports Joint Healing
Enrico Ragni, Marco Viganò, Enrica Torretta, Carlotta Perucca Orfei, Alessandra Colombini, Carlo Tremolada, Cecilia Gelfi, Laura de Girolamo · Journal of Clinical Medicine · 2022
Micro-fragmentation removes blood while preserving healing cells
Researchers at a leading Italian orthopedic institute wanted to understand exactly what makes processed fat tissue effective for treating osteoarthritis. They compared standard liposuction samples with micro-fragmented adipose tissue (specially processed fat) from seven patients. The processing removed blood cells that can cause inflammation while keeping the helpful cells intact.
This matters because blood residues left in treatment products can trigger unwanted inflammatory responses. The micro-fragmentation process washes these away using gentle mechanical action and saline solution—no enzymes or harsh chemicals needed.
Fat tissue contains multiple types of healing cells
The study confirmed that processed fat tissue retains several important cell types:
Pericytes: Helper cells that wrap around small blood vessels and can transform into regenerative cells when needed
Mesenchymal stromal cells (MSCs): Cells that sense damaged tissue and release healing signals
Endothelial cells: Cells that line blood vessels and support tissue structure
Using advanced microscopy and cell analysis, researchers showed the micro-fragmentation process keeps the natural tissue structure largely intact. This preserved architecture helps cells function normally after injection.
Processed tissue releases protective molecular signals
One of the most significant findings involved tiny particles called extracellular vesicles. These microscopic packages carry healing molecules from cell to cell. Researchers identified over 380 different signaling molecules (called miRNAs) within these vesicles.
The most abundant molecules matched those known to:
Protect cartilage from breakdown
Encourage anti-inflammatory immune responses
Support tissue repair processes
Importantly, molecules associated with blood cells—which could worsen inflammation—were present in much smaller amounts after processing.
Harmful inflammatory proteins reduced after processing
Using advanced protein analysis, researchers found that micro-fragmentation reduced certain proteins linked to osteoarthritis progression. These "acute phase factors" typically drive inflammation and joint damage. Their reduction suggests the processed tissue may be better suited for treating inflamed joints.
The secretome (the collection of substances released by the tissue) showed a more favorable profile for joint healing compared to unprocessed fat samples.
What this means for osteoarthritis patients
This laboratory study helps explain why clinical trials have shown positive results with micro-fragmented adipose tissue for knee osteoarthritis. The processing method appears to:
Remove potentially harmful blood components
Preserve the cells responsible for healing
Maintain a rich supply of protective signaling molecules
Reduce inflammatory factors that worsen joint disease
While this was not a clinical trial measuring patient outcomes, it provides important scientific evidence about how the treatment works at a cellular level. The researchers concluded that micro-fragmentation is a "safe and efficient method" for preparing adipose tissue to treat musculoskeletal conditions.
Key takeaways for treatment decisions
For patients considering Lipogems® treatment, this research confirms several important points. The processing technology genuinely refines the fat tissue rather than simply relocating it. The resulting product contains active healing components while minimizing potentially harmful substances. These laboratory findings support the positive outcomes reported in separate clinical studies of joint pain and function.
As with any medical decision, discussing your specific situation with a qualified healthcare provider remains essential.
---
Source: Ragni et al., Journal of Clinical Medicine, 2022.
Original Publication
Characterization of Microfragmented Adipose Tissue Architecture, Mesenchymal Stromal Cell Content and Release of Paracrine Mediators
Enrico Ragni, Marco Viganò, Enrica Torretta, Carlotta Perucca Orfei, Alessandra Colombini, Carlo Tremolada, Cecilia Gelfi, Laura de Girolamo · Journal of Clinical Medicine · 2022
This study characterizes microfragmented adipose tissue (µFAT) for osteoarthritis treatment by analyzing its structure, cell content, and paracrine mediators compared to unprocessed lipoaspirate (LA). Adipose tissue from 7 donors was processed using mild mechanical fragmentation without enzymes or centrifugation. Histological and flow cytometry analyses revealed that µFAT retained structural, endothelial, and stromal components including pericytes while reducing blood cell content compared to LA. High-throughput qRT-PCR identified 376 and 381 extracellular vesicle (EV)-embedded miRNAs in LA and µFAT respectively. The most abundant µFAT-upregulated EV-miRNAs were predominantly ASC-EV-specific molecules involved in cartilage protection and M2 macrophage polarization, with minimal blood cell-related miRNAs. Proteomic analysis of the secretome showed µFAT had reduced levels of acute phase factors associated with OA progression compared to LA. Results demonstrate that microfragmentation removes blood elements while preserving tissue architecture and stromal cell populations, potentially enhancing OA-protective molecular features. The maintained tissue microarchitecture increases the surface-to-volume ratio, improving accessibility of therapeutically active cells like MSCs and pericytes. These findings suggest µFAT represents a safe and efficient method for applying adipose tissue's regenerative properties to musculoskeletal disorders, with mechanisms of action involving paracrine signaling through both soluble factors and extracellular vesicles.